| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 4, Issue 6 461-466, Copyright © 1993 by American Association of Cancer Research
ARTICLES |
G Vairo and JA Hamilton
Department of Medicine, University of Melbourne, Parkville, Australia.
Although increased Na+/H+ exchange (antiport) activity has been shown to precede both granulocytic and monocytic differentiation of HL60 cells, its requirement for this process remains controversial. We show here that, in the absence of HCO3-, the Na+/H+ exchanger is the predominant mechanism involved in rapid recovery of pHi from cytoplasmic acidosis; however, in the presence of HCO3-, other mechanisms also contribute to pHi homeostasis. In the absence of HCO3-, dimethyl sulfoxide and 4 beta-phorbol 12-myristate 13 alpha-acetate result in an acute activation of antiport activity, whereas all-trans-retinoic acid, 1,25-dihydroxyvitamin D3, gamma-interferon, and tumor necrosis factor alpha do not. Furthermore, whether or not HCO3- is present, the amiloride analogue, 5-N,N-dimethylamiloride, a potent and more specific antiport inhibitor than the parent compound, failed to suppress HL60 cell proliferation or the decreased proliferation in response to dimethyl sulfoxide, all-trans-retinoic acid, 1,25-dihydroxyvitamin D3, gamma-interferon, or tumor necrosis factor alpha. In the absence of HCO3-, 5-N,N-dimethylamiloride also had little effect on the ability of these agents to induce functional maturation as assessed by acquisition of respiratory burst activity. Inhibition of antiport activity also did not prevent 4 beta-phorbol 12-myristate 13 alpha-acetate-induced expression of c-fos mRNA or cell adherence. The results suggest that, even under conditions in which the Na+/H+ exchanger is the predominant operable pHi regulator, antiport activity is not required for HL60 proliferation or differentiation.
This article has been cited by other articles:
![]() |
C. V. Rieder and L. Fliegel Developmental regulation of Na+/H+ exchanger expression in fetal and neonatal mice Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H273 - H283. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Besson, F. Fernandez-Rachubinski, W. Yang, and L. Fliegel Regulation of Na+/H+ exchanger gene expression: mitogenic stimulation increases NHE1 promoter activity Am J Physiol Cell Physiol, March 1, 1998; 274(3): C831 - C839. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang, D. Singh, and L. Fliegel The Na+/H+ Antiporter Potentiates Growth and Retinoic Acid-induced Differentiation of P19 Embryonal Carcinoma Cells J. Biol. Chem., October 17, 1997; 272(42): 26545 - 26549. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yang, H. Wang, and L. Fliegel Regulation of Na+/H+ Exchanger Gene Expression. ROLE OF A NOVEL POLY(dAˇdT) ELEMENT IN REGULATION OF THE NHE1 PROMOTER J. Biol. Chem., August 23, 1996; 271(34): 20444 - 20449. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. B. Dyck and L. Fliegel Specific Activation of the Na[IMAGE]/H[IMAGE] Exchanger Gene during Neuronal Differentiation of Embryonal Carcinoma Cells J. Biol. Chem., May 5, 1995; 270(18): 10420 - 10427. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |